10/22/2012
NBT Research Report
Initial report is not available yet. Check back soon!
Investor Presentation
No Slideshow. Check back later for the latest.

Free signup
  • FREE RESEARCH REPORTS ($250 value)
  • WEEKLY BRIEFINGS ON EMERGING GROWTH COMPANIES
Home >> 10 Compelling Reasons to Own GlyEco BEFORE Wall Street Gets On Board
Your rating: None Average: 1 (2 votes)
10 Compelling Reasons to Own GlyEco BEFORE Wall Street Gets On Board
By Tobin Smith | August 29, 2012, 5:39pm GMT Aug 29 2012

Dr. John Faessel, an independent equities research pro for whom we at NBT respect highly, has been on the GlyEco (GLYE) bandwagon since early this year. Although he is an alumni of my arch rival USC (me being a UCLA guy) I value his research work highly.

Since they are in their “quiet period” on an equity raise, we have not been able to publish our sponsored research on GLYE—that’s the rules (for now—SEC meeting today on “quiet period” insanity to change to 21st century).

He calls GLYE a “Speculation Par Excellence”—with this equity round done we strongly believe it moves up the food chain to highly profitable emerging growth company without equal.

Quick snapshot:

Management’s revenue/earnings projections from the 7 acquisitions already concluded:

- year one EPS are projected at $0.40 a share

- projected 2012 revenue is $6 million

- projected 2013 revenue is $48 million

- projected 2014 revenue is $73 million

Source

About the Author

Founder and Editor-in-Chief NBTEquitiesResearch.com. Contributor and Anchor Fox News Channel and Fox Business Network. Chairman & CEO NBT Group,Inc., a boutique private capital investment bank and investor relations organization.

Contact | Follow Tobin Smith on   Twitter | Facebook
.
Join the Conversation: Let's Talk About It, Baby!
©2010-2012 NBT Group. All Rights Reserved  |  Privacy Policy
Website Design by Amanda Besemer + Co.